Prot# 13G01: A Phase 1 Dose Escalation Study of Repeat Intra-Articular Administration of tgAAC94, A Recombinant Adeno-Associated Vector Containing the TNFR:Fc Fusion Gene, in Inflammatory Arthritis Subjects With and Without Concurrent TNF-alpha Antagonist

Project: Research project

Project Details

StatusFinished
Effective start/end date1/23/069/9/10

Funding

  • Targeted Genetics Corporation (13G01)